Dual 64Cu-DOTATATE and 18F-FDG PET/CT Imaging of Patients With Neuroendocrine Neoplasms

PHASE2Enrolling by invitationINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

January 17, 2023

Primary Completion Date

January 1, 2025

Study Completion Date

January 1, 2026

Conditions

GEP-NETNeuroendocrine TumorsNeuroendocrine CarcinomaNeuroendocrine Carcinoma Metastatic

Interventions

DRUG

18F-FDG

PET/CT scan approximately 60 min after injection of 18F-FDG

DRUG

64Cu-Dotatate

PET/CT scan approximately 60 min after injection of 64Cu-Dotatate

Trial Locations (1)

Rigshospitalet, Copenhagen

All Listed Sponsors

lead

Rigshospitalet, Denmark

OTHER